An exploratory qualitative assessment of patient and clinician perspectives on patient-reported outcome measures and disease-modifying therapies in adults with spinal muscular atrophy

J Rehabil Med. 2025 Jan 14:57:jrm41254. doi: 10.2340/jrm.v57.41254.

Abstract

Objective: To understand patient, caregiver, and clinician perspectives on patient-reported outcome measures, critical functional domains, and disease-modifying therapies in adult spinal muscular atrophy.

Design: An exploratory qualitative single-site study.

Patients: Ten adults with spinal muscular atrophy and two clinicians participated in semi-structured interviews.

Methods: Semi-structured interviews were conducted virtually or in person with participants after they completed outcome measures at a routine clinic visit. Two researchers analysed transcripts concurrently using a thematic approach to determine themes.

Results: Ten themes were identified among partici-pants. Patient-reported outcome measure preference varied between functional groups and was under-responsive, although it captured meaningful data. Motor stability was most frequently expected with disease-modifying therapy, but participants also reported improved fatigue and respiratory status.

Conclusion: After considering patient goals, functional status, and preferences, patient-reported outcome measures represent a valuable adjunct to standard clinical and research tools. Optimal selection of patient-reported outcome measures requires careful consideration of multiple patient factors. Collaborative development of modified patient-reported outcome measures may yield a responsive, meaningful, and acceptable tool that can be used across a broad functional spectrum.

MeSH terms

  • Adult
  • Caregivers / psychology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Muscular Atrophy, Spinal*
  • Patient Reported Outcome Measures*
  • Qualitative Research*

Grants and funding

This study was approved by the Horizon Health Research Ethics Board (File Number 101329). All participants provided informed consent to participate in the study. This project received funding from ResearchNB, the Faculty of Medicine at Dalhousie University, and Hoffman-La Roche Limited.